PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New label-free imaging tracks cancer treatment in single cells

2025-07-14
(Press-News.org) Spotting the Missteps: How MiROM Detects Protein Misfolding in Cancer Cells
MiROM identifies proteins by using mid-infrared light to detect molecular vibrations – essentially the natural “dance” of molecules within protein structures. Unlike optical spectroscopy, which measures light attenuation, optoacoustics capture ultrasound waves generated when proteins absorb infrared light. This absorption causes a tiny, localized temperature increase, leading to transient expansion of medium surrounding the protein and the emission of ultrasound waves. By analyzing these signals in real time, MiROM can detect structural changes in proteins, such as misfolding, by recognizing shifts in their molecular “dance”. This capability provides crucial insights into how cancer cells respond to treatment.

Overcoming Limitations in Myeloma Therapy Assessment
Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma treatment often require large cell samples, complex preparation, and time-intensive measurements, making it challenging to monitor individual patient responses in a timely manner.

MiROM overcomes these limitations by analyzing single cells, requiring only a minimal number of patient samples, and providing fast, nearly real-time assessments of treatment effectiveness.

“Since MiROM can analyze individual cells in real time without the need for elaborate sample preparation, it offers fast insights into how treatments may impact protein structures at a cellular level,” says Francesca Gasparin, first author of the study. “Specifically, MiROM detects the formation of intermolecular beta-sheets (structures linked to protein misfolding) as well as apoptosis, the programmed cell death that indicates whether cancer treatments are working or if drug resistance is developing,” add Prof. Miguel Pleitez and Prof. Florian Basserman, senior investigators in the study.

By analyzing individual cells, MiROM can uncover variations in treatment response within a patient’s cancer, paving the way for truly personalized therapy adjustments.

One Tool, Many Applications
Beyond multiple myeloma, MiROM holds great potential for other diseases linked to protein misfolding, including Alzheimer’s and Parkinson’s. Ongoing advancements – including optimizing laser pulse duration and increasing imaging speed – could further enhance its sensitivity and broaden its clinical applications.

“We envision the use of MiROM in drug screening, diagnostic tests and home-based patient monitoring,” says Prof. Vasilis Ntziachristos, also a senior investigator in the study. Future clinical validation in larger patient cohorts will be the next step toward bringing this technology into routine medical practice.

 

About the Researchers
Prof. Vasilis Ntziachristos, Head of the Bioengineering Center and the Institute of Biological and Medical Imaging at Helmholtz Munich. He also holds the Chair of Biological Imaging at the Technical University of Munich (TUM) and is a founding member and in the Board of Directors of TranslaTUM, TUM's Central Institute for Translational Cancer Research. At TranslaTUM, researchers from medicine, engineering, and natural sciences collaborate to rapidly translate cancer research discoveries into clinical applications.
Francesca Gasparin, Researcher at the Institute of Biological and Medical Imaging at Helmholtz Munich and the Chair of Biological Imaging at the Technical University of Munich (TUM).
Prof. Miguel A. Pleitez, Group Leader for Translational Optoacoustics at the Institute of Biological and Medical Imaging at Helmholtz Munich, Chair of Biological Imaging at the Technical University of Munich (TUM), Group leader at TranslaTUM.
Prof. Florian Bassermann, Director of the Department of Medicine III (Hematology/Oncology), TUM University Hospital, Technical University of Munich (TUM), Group leader at TranslaTUM.

About Helmholtz Munich
Helmholtz Munich is a leading biomedical research center. Its mission is to develop breakthrough solutions for better health in a rapidly changing world. Interdisciplinary research teams focus on environmentally triggered diseases, especially the therapy and prevention of diabetes, obesity, allergies, and chronic lung diseases. With the power of artificial intelligence and bioengineering, researchers accelerate the translation to patients. Helmholtz Munich has around 2,500 employees and is headquartered in Munich/Neuherberg. It is a member of the Helmholtz Association, with more than 43,000 employees and 18 research centers the largest scientific organization in Germany. More about Helmholtz Munich (Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH): www.helmholtz-munich.de/en     

END


ELSE PRESS RELEASES FROM THIS DATE:

So what do the world’s coastlines look like in 2025?

2025-07-14
At the dawn of the millennium, a group of eminent scientists began compiling a list of the threats they felt were most likely to impact the world’s rocky shorelines over the coming quarter of a century. Published in 2002, it included forecasts that – among other things – pollution from oil spills would decrease, the number of invasive species across the world would rise, genetically-modified organisms would have harmful effects on the ocean, and the impacts of global climate change would be felt more intensely. Now, 25 years on, the same academics – along with a larger and more wide-ranging team of international experts – have revisited ...

High-purity green hydrogen with very low tar from biomass, with chemical looping gasification

2025-07-14
A promising industrial process can turn crushed sugar cane waste into green hydrogen far more efficiently than previously thought, shows a SECLG process simulation from the University of Johannesburg. The study is published in Renewable Energy. The simulation indicates high energy efficiency and produces a small fraction of the unwanted tar, carbon monoxide (CO), carbon dioxide (CO2), and nitrogen (N) compared to conventional biomass gasification plants. The process may assist in decarbonizing energy-intensive industries such as steel and cement in the future. Sugar cane and ...

Not all "forever chemicals" are equal: Experts call for nuanced PFAS policy to protect human and public health and the environment

2025-07-14
The public, legislators, and media often group per- and polyfluoroalkyl substances, known as PFAS or “forever chemicals,” which are found globally in countless products, into a single category. While certain PFAS are harmful for human and public health, new articles in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier, emphasize that fluoropolymers, a specific class of PFAS, are not considered environmental contaminants and are indispensable for use in medical devices. ...

‘Hope isn’t enough – we need action when it comes to climate change’, an earth scientist’s guide for the future

2025-07-14
Climate change is coming… but what on Earth can we do about it? Scientist Dr. Kimberley Miner has written a guide to riding out the oncoming almighty storm. Miner is an Earth scientist whose research includes studying the changing Poles of Earth, the Arctic’s melting permafrost, forever chemicals and plastic pollution. Her new book Considering Climate Change provides practical guidance for young people concerned about the future. She poses questions like how to deal with eco-anxiety and climate-grief, how to prepare financially, ...

Obesity rates in Canada increased after start of COVID-19 pandemic

2025-07-14
Did the COVID-19 pandemic affect obesity rates in Canada? A new study in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.241421 found obesity rates based on body mass index (BMI) increased faster in the 4 years after the start of the pandemic than in the previous 11 years, especially in younger adults. “Compared with the average increase during the 11 years before the pandemic, the prevalence of obesity [as measured by BMI] increased at a greater rate during the 4 years after the onset of the COVID-19 pandemic (2020–2023), suggesting that the COVID-19 pandemic and associated public health restrictions ...

Supporting autistic patients in health care

2025-07-14
Caring for autistic patients requires a unique approach, and a Five ways to support… article in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250152 aims to provide tips on caring for these patients. Suggestions include offering online bookings and virtual consultations, adapting health care delivery and environments to reduce sensory overstimulation, tailoring communications for individual patients, ensuring clarity and predictability in health care encounters, ...

New study finds sharp increase in nicotine pouch ingestions among young children

2025-07-14
(COLUMBUS, Ohio) – A new study reveals that ingestions of nicotine pouches by young children have surged in recent years. Researchers at the Center for Injury Research and Policy of the Abigail Wexner Research Institute at Nationwide Children’s Hospital and the Central Ohio Poison Center analyzed calls to U.S. poison centers and found an alarming 763% increase in the rate of reported nicotine pouch ingestions among children younger than 6 years old from 2020 to 2023. Nicotine pouches were also more ...

LIGO-Virgo-KAGRA detect most massive black hole merger to date

2025-07-13
The LIGO-Virgo-KAGRA (LVK) Collaboration has detected the merger of the most massive black holes ever observed with gravitational waves using the US National Science Foundation (NSF)-funded LIGO observatories. The powerful merger produced a final black hole approximately 225 times the mass of our Sun. The signal, designated GW231123, was detected during the fourth observing run of the LVK network on November 23, 2023. LIGO, the Laser Interferometer Gravitational-wave Observatory, made history in 2015 when it made the first-ever direct detection of gravitational waves, ripples in space-time. In that case, the waves emanated from a black ...

Lonely adults may have a higher risk of diabetes

2025-07-13
SAN FRANCISCO—Socially isolated older adults are at increased risk of developing diabetes and high blood sugar, according to a study being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “Social isolation and loneliness have been increasingly recognized as important health risk factors after the COVID-19 pandemic. Our findings underscore the importance for clinicians to recognize social isolation as a critical social determinant of health when ...

Intermittent energy restriction may improve outcomes in people with obesity and type 2 diabetes

2025-07-13
SAN FRANCISCO—Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels and body weight in people with obesity and type 2 diabetes, according to a study being presented Sunday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “This study is the first to compare the effects of three different dietary interventions intermittent energy restriction (IER), time-restricted eating (TRE) and continuous energy restriction (CER) in managing type 2 diabetes with obesity,” said Haohao Zhang, Ph.D., chief physician ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] New label-free imaging tracks cancer treatment in single cells